Previous Article | Next Article 
Journal of Clinical Microbiology, September 1998, p. 2465-2470, Vol. 36, No. 9
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Necessity of Molecular Techniques To Distinguish
between Neisseria meningitidis Strains Isolated from
Patients with Meningococcal Disease and from Their
Healthy Contacts
Ulrich
Vogel,1
Giovanna
Morelli,2
Kerstin
Zurth,2
Heike
Claus,1
Eugen
Kriener,3
Mark
Achtman,2,* and
Matthias
Frosch1
Institut für Hygiene und Mikrobiologie,
Universität Würzburg,1 and
Gesundheitsamt im Landratsamts
Würzburg,3 Würzburg, and
Max-Planck-Institut für molekulare Genetik,
Berlin,2 Germany
Received 12 February 1998/Returned for modification 24 April
1998/Accepted 21 May 1998
 |
ABSTRACT |
Serogroup C strains of Neisseria meningitidis were
isolated from a Germany patient with severe meningococcal disease
after a trip to the Czech Republic. These strains (case isolates) were characterized by classical and molecular techniques, as were other strains (carrier isolates) isolated from healthy contacts. Five of 10 carrier isolates had switched off the expression of capsular polysaccharide, as demonstrated by a serogroup-specific PCR. The two
case isolates were indistinguishable by multilocus sequence typing and
belonged to the ET-37 complex. The carrier isolates belonged to four
different sequence types, all unrelated to that of the case strains.
Pulsed-field gel electrophoresis showed that the case isolates differed
from reference ET-37 complex strains from the Czech Republic and Canada
as well as from all the carrier isolates. The isolate from the
patient's nasopharynx was indistinguishable from the blood isolate
except for a 40,000-bp chromosomal deletion that had occurred during
systemic spread.
 |
INTRODUCTION |
Bacterial meningitis due to
Neisseria meningitidis (the meningococcus) continues to be
of global importance for public health authorities. While pandemics
affecting China and Africa are usually caused by meningococci of the A
capsular serogroup, sporadic meningitis, outbreaks, and hyperendemic
disease in Central Europe and the United States are usually
caused by serogroups B and C (2). For sporadic
meningococcal meningitis, public health efforts often include
bacteriological analysis of throat swabs obtained from close contacts
of the patient and the treatment of healthy nasopharyngeal carriers
with prophylactic antibiotics and/or vaccines (5).
Meningococci isolated from the healthy contacts of a diseased patient
(carrier isolates) are not necessarily related to the strain causing
disease (case isolates), even if all these isolates express the same
capsular serogroup. Various subtyping methods have been used to test
relationships among the strains from a cohort, including serotyping and
serosubtyping with monoclonal antibodies (MAbs) (11),
pulsed-field gel electrophoresis (PFGE) (7),
multilocus enzyme electrophoresis (MLEE) (2),
ribotyping (22), the randomly amplified polymorphic DNA
method (25), and PCR-restriction fragment length
polymorphism analysis (16). Recently, a novel portable
approach, multilocus sequence typing (MLST), which is based on the DNA
sequences of six housekeeping gene fragments, has been developed
(18). MLST allows assignment of meningococci to clonal
groups within a globally accessible, continuously expanding central
database.
In outbreak situations, so many bacteria may be isolated that only some
of the carrier strains, usually selected on the basis of their capsular
serogroup by latex agglutination, are evaluated in detail. However, the
expression of capsular polysaccharide by serogroup B meningococci can
undergo phase variation, resulting in the isolation of strains from
carriers which are not obviously related to the index strain because
they are capsule negative and nonserogroupable (6, 14, 15).
The siaD gene encodes a polysialyltransferase which is
needed for the synthesis of capsular polysialic acid chains.
siaD can be amplified from serogroup B and C meningococci by
PCRs (6), enabling the determination of the
potential serogroups of bacteria which have become phenotypically nonserogroupable. Here we describe a two-step PCR, an improved version
of the siaD PCR (6), which distinguishes between
serogroup B, C, W135, and Y meningococci.
Antigenic variation through horizontal genetic exchange can also lead
to capsule switching among highly related bacteria (23). Such capsule-switching variants would be classified as
unrelated to the parent strain by classical serogrouping.
Similarly, antigenic variation can also lead to the switching of
other antigens (13), including those used for
serological subtyping, such as PorA (21). Thus, serological
methods cannot reliably recognize the relatedness of meningococci and
epidemiological analyses should rely primarily on molecular techniques,
particularly those based on multiple loci scattered around the
chromosome (3).
We report here on the molecular investigation of meningococci isolated
from individuals who had been in contact with a patient with severe
serogroup C meningococcal disease.
 |
MATERIALS AND METHODS |
Meningococcal isolates, culture conditions, and
identification.
Blood cultures were performed with the BactT/Alert
System from Organon Teknika (Durham, N.C.). Cerebrospinal fluid was
cultured on Columbia blood agar (Difco, Augsburg, Germany) and
chocolate agar (Difco), and enrichment cultures were performed with
brain heart infusion medium (Difco) supplemented with factors V and X
(Difco). Nasopharyngeal swabs from 60 individuals with contact with the
index patient were cultured on chocolate agar plates. After overnight
growth at 37°C in a 5% CO2 atmosphere, colonies containing oxidase-positive, gram-negative diplococci were tested with
the RAPID NH System (LD Labor Diagnostika, Leiden, Germany) for the
biotyping of Neisseria and Haemophilus.
Serogrouping was performed by latex agglutination with the Directigen
Meningitis Combo Test (Becton Dickinson, Meylan, France) and by an
enzyme-linked immunosorbent assay (ELISA) with the following MAbs: MAb
1087 (specific for the serogroup A capsule), MAb 735 (serogroup B), MAbs 924 and 1125 (serogroup C), MAb 1508 (serogroup W135), and MAb
1938 (serogroup Y). For the ELISA, meningococci were grown overnight on
chocolate agar, and 20 µl of a bacterial suspension (optical density
at 600 nm = 0.15) was added to each well of a microtiter plate
(Greiner, Solingen, Germany) which had been coated with
poly-D-lysine (Sigma). After drying, the bacteria were
fixed with phosphate-buffered saline (PBS)-0.05% glutaraldehyde for 10 min at room temperature. Thereafter, nonspecific binding sites were
blocked by incubation with PBS-1% bovine serum albumin for 1 h
at 37°C. Binding of the anticapsule antibodies and of a secondary peroxidase-conjugated anti-mouse immunoglobulin antibody (Dianova, Hamburg, Germany) was performed for 1 h in PBS-1% bovine serum albumin. Intermediate wash steps were performed with PBS. ET-37 reference strains were a kind gift of Dominique A. Caugant (World Health Organization Collaborating Centre for Reference and Research on
Meningococci, National Institute of Public Health, Oslo, Norway). Serogroup B isolate B1940 has been described elsewhere (9), and the reference serogroup W135 and Y strains were ATCC 750020 and
ATCC 55989, respectively.
Serotyping.
The serotypes and serosubtypes of the
meningococcal isolates were determined by a previously described ELISA
(1) with a set of serotype-specific (2a, 2b, 4, 14, 15, and
21) and serosubtype-specific (P1.1 through P1.15) antibodies, which
were provided by J. Suker and I. Feavers (National Institute for
Biological Standards and Control, Hertfordshire, United Kingdom).
cps PCR.
The siaA, siaB,
and siaC genes of region A of the cps locus
(9, 23) yielded a 2-kb product after amplification by colony PCR with primers SH39 and UE16 (Table 1).
The PCR conditions were initial denaturation (94°C, 5 min), followed
by 36 cycles of annealing (45°C, 1 min), extension (72°C, 90 s), and denaturation (94°C, 1 min) and then one cycle of annealing
(45°C, 1 min) and a final extension (72°C, 10 min). The PCR
conditions for the amplification of the siaD genes (9,
10, 23) were the same, except that the following annealing
temperatures (product sizes) were used: 52°C for primers UE12-UE13
(1.8 kb), 40°C for primers HC2-HC4 (2.1 kb), and 50°C for primers
HC39-HC50 (extension time, 2 min; 2.4 kb) and primers HC44-HC50
(extension time, 2 min; 3.2 kb). The recently described siaD
(B/C) PCR with primers B/CsiaD1 and B/CsiaD2, which exclusively amplify
serogroup B and C genes (6), was also performed as a
control.
PFGE.
PFGE was performed as described previously
(19) after digestion of the DNA blocks with the restriction
endonucleases SpeI and NheI.
MLST.
The sequences of fragments from the abcZ,
adk, aroE, gdh, pdhC, and
pgm genes were determined as described previously
(18) and were compared to the sequences of formerly known
alleles. Novel allelic variants were assigned the allelic designations adk13 (ST54), aroE20 (ST54), and gdh18
(ST55). New combinations of the six alleles were assigned the
designations ST54 through ST56 (see http://mlst.zoo.ox.ac.uk).
 |
RESULTS |
Epidemiological description and properties of strains.
A
German male (age, 17 years) developed severe meningococcal septicemia
and skin hemorrhaging on his return to Germany from Prague, Czech
Republic, where he had attended an international youth gathering with a
group of German scouts for 3 days. Serogroup C N. meningitidis was isolated from cultures of both blood (strain 2120) and nasopharyngeal swabs (strain 2121) from the patient; no
bacteria could be cultivated from the cerebrospinal fluid. Strains 2120 and 2121 were nonserotypeable and were of the P1.5,2 serosubtype.
Disease outbreaks in the Czech Republic since 1993 have been caused by
serogroup C meningococci of the ET-37 complex, usually serotype 2a and
serosubtype P1.5,2 (17). Such Czech strains belong to a
particular MLEE electrophoretic type (ET) called ET-15 (17),
which has also caused hyperendemic disease in Canada (4).
The patient recovered without complications after treatment with
penicillin.
Nasopharyngeal swabs were obtained by general practitioners and the
local health authorities from 60 individuals who had been in contact
with the patient. Of those, 47 were scouts aged 15 to 21 years who had
also attended the youth gathering. Thirteen other swabs were obtained
from individuals who had accompanied the scouts, from the families of
two of the scouts (scouts 1 and 2, Table
2), or from unspecified sources. Ten
meningococci were isolated from 9 of the 60 individuals who had been
swabbed (Table 2). Five of the isolates were nonserogroupable, three
were serogroup C, and two were serogroup B. The serotypes and
serosubtypes of the carrier isolates are also given in Table 2. Only
strain 2125 exhibited a serosubtype identical to that of the index
strain. However, that strain was serotype 4, whereas the index strain was nonserotypeable.
Serogroup-specific PCR.
In order to determine the capsular
genotypes of the nongroupable isolates, PCRs which can amplify the
siaA to siaC and siaD genes,
respectively, of region A from serogroup B, C, W135, or Y meningococci
were developed. Region A of the cps locus contains the genes
required for the synthesis of activated sialic acid (siaA to
siaC) and for the polymerization of sialic acid
(siaD). The siaA to siaC genes are
identical in serogroups B, C, W135, and Y (9, 10, 23). Thus,
the siaA to siaC PCR allows the differentiation
of serogroups B, C, W135, and Y from the other serogroups of
meningococci. In contrast, the siaD genes of serogroup B and
C meningococci are 64% identical and differ considerably from the
siaD genes of serogroups W135 and Y, which are 98%
identical (9, 10, 23). Primers which bind to unique upstream
and downstream regions flanking siaD were developed to
distinguish serogroups B and C. The homology between the
siaD genes of serogroup W135 and Y strains is so high that a
common reverse primer was used together with serogroup-specific
forward primers which bind within the siaD gene (Table 1).
The siaD PCR yielded a larger DNA fragment with
serogroup Y strains than with serogroup W135 strains due to a 630-bp
insertion in the region downstream of siaD which is present
among all serogroup Y strains analyzed to date (11a). Thus,
these serogroups can be distinguished among reference strains by
siaD PCRs.
We evaluated whether these PCR tests can reliably distinguish capsular
genotypes B, C, W135, and Y with a small series of representative
meningococcal isolates from our strain collection (serogroups B [seven
strains], C [six strains], W135 [three strains], Y [four
strains], and A [six strains]) and with two strains of Neisseria lactamica. The sensitivity of the siaA
to siaC PCR was 100% because it yielded a product with all
the strains of serogroups B, C, W135, and Y but with none of the
strains of serogroup A or the N. lactamica strains. With the
same set of strains, the sensitivity of the siaD PCR was
85% (seven of seven serogroup B strains, five of six serogroup C
strains, two of three serogroup W135 strains, and three of four
serogroup Y strains were positive).
The isolates from healthy contacts analyzed in this study were tested
by the siaA to siaC and siaD PCRs and
as confirmation, by the siaD (B/C) PCR (6), which
amplifies internal fragments of the siaD gene from all
serogroup B and C meningococci with a single primer pair. Three of the
five nonserogroupable meningococci yielded a positive result in the
siaA to siaC PCR (Fig.
1), while the other two, strains 2125 and
2126, were negative by all PCR tests and do not contain genes for
capsular polysaccharide B, C, W135, or Y. One of the three strains with
a positive siaA to siaC PCR result yielded a
specific product by the serogroup Y siaD PCR (genotype Y)
(Fig. 1), while the other two strains were positive by the serogroup C
siaD PCR (genotype C). One of the latter two strains (strain
2122) had been isolated from a swab which also yielded a typical
serogroup C strain (strain 2123).

View larger version (81K):
[in this window]
[in a new window]
|
FIG. 1.
Determination of the capsular genotype of
nonserogroupable carrier strains by PCR amplification of sia
genes. The strains tested are listed at the top, and the molecular
sizes of the standards are given on the left. Lanes: , negative
control without template DNA; B, serogroup B strain B1940
(9); C, index strain 2120 (serogroup C, this study); W,
serogroup W135 strain (ATCC 750020); Y, serogroup Y strain (ATCC
55989), other numbers at the top are nonserogroupable carrier
isolates.
|
|
MLST.
The MLST procedure, which consists of the
sequencing of six independent gene fragments (18), was
applied to the two strains isolated from the patient, seven of the
carrier isolates, and two representative ET-15 strains of the ET-37
complex (strain 259/43 from the Czech Republic and strain 88/048 from
Canada). Both case isolates and both representative ET-15 strains were ST11, the sequence type (ST) most commonly associated with strains of
the ET-37 complex.
All carrier isolates except strain 2118 belonged to novel STs, labelled
54 through 56; serogroup B strain 2118 was ST32, which is
characteristic of the ET-5 complex (Table 2). Thus, none of the carrier
strains was related to the strains from the patient. Four of the
carrier strains, three serogroup C strains and one genotype C strain,
were ST55 and NT:P1.15 or 4:P1.15. These strains had been isolated from
two brothers who had also visited the youth gathering and from their
mother. The boys' father carried the unrelated genotype Y strain of
ST56. ST56 is related to ST12 (five of six alleles are identical) and
ST13 (four of six alleles are identical), which were isolated from
healthy carriers in Norway (18). STs 54 and 55 are not
closely related to previously defined STs since they differed from all
of them by at least two alleles.
PFGE.
MLST is a highly conservative genotyping method that is
insensitive to microevolution and that is therefore highly suitable for
determining relationships between bacterial strains and for long-term
epidemiology. In contrast, PFGE is very sensitive to microevolution and
can reveal minor differences between related strains (19).
Bacterial DNA was analyzed by PFGE after digestion with SpeI
and NheI to determine if minor differences distinguished any
of the related strains (Fig.
2). Several bands
differed between the ST11 strains isolated in Canada and the Czech
Republic and between either of those bacteria and the ST11 isolates
from the throat and blood of the German patient. In contrast, the
latter two strains were almost identical, except that after digestion with SpeI, the DNA from the throat isolate yielded a
fragment of 170 kb, while the DNA from the blood isolate yielded a
fragment of 130 kb. Similarly, after NheI digestion, the
throat isolate yielded a 160-kb band while the blood isolate yielded a
120-kb band (Fig. 2). These results suggest that this strain had
suffered a 40-kb deletion during invasion from the throat to the
bloodstream. No differences were observed between the four ST55
isolates after digestion with NheI, and three of those
isolates, including strains 2122 (nongroupable, genotype C) and 2123 (serogroup C) isolated from a carrier (scout 2) were also
indistinguishable after digestion with SpeI. The other three
carrier isolates (ST32, ST54, and ST56, respectively) yielded unique
PFGE patterns, as expected.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 2.
PFGE analysis of case and carrier strains after
digestion with SpeI or NheI. The
strains tested and their STs are indicated at the top of each panel,
and the positions of molecular weight (MW) markers are given on
the left. Representative ET-15 strains from Canada (strain 88/048) and
the Czech Republic (strain 259/43) are next to the isolates from the
blood (strain 2120) and throat (strain 2121) from the index patient.
Other strains were isolated from carriers and are described in Table 2.
The positions of the bands which differ between strains 2120 and 2121 are indicated by asterisks.
|
|
 |
DISCUSSION |
A serogroup C strain was isolated from a patient who had returned
from the Czech Republic where serogroup C ET-37 complex meningococci
have recently caused epidemics of meningitis and septicemia
(17). Due to the increased risk of disease among the
contacts of patients with sporadic cases of meningococcal disease,
close contacts were offered prophylactic antibiotic therapy and their
carrier status was determined in order to estimate whether the index
strain had spread. The data presented here demonstrate that
serogrouping of meningococci isolated from healthy carriers is an
inadequate criterion for determining spread. The molecular mechanisms
of reversible capsule phase variation have recently been elucidated for
serogroup B meningococci (14, 15), and the data presented
here suggest that capsule phase variation (whose mechanism remains to
be elucidated) may also occur among serogroup C meningococci. Two
highly related meningococci were isolated from one healthy carrier, and
the meningococci were identical by MLST and PFGE analysis but differed
in their expression of the C polysaccharide. Two other carrier isolates
possessed genes for the expression of the C or the Y polysaccharide,
although they were nonserogroupable. If the results for serogroup B
meningococci can be extrapolated, these nonserogroupable strains are
potentially capable of reversion to encapsulation and are potential
sources of disease. These observations indicate that serogrouping of
carrier isolates should rely on molecular techniques as well as on
classical serological methods. The PCR methods described here allow
determination of the B, C, W135, and Y capsular genotypes within 2 days
after colony isolation and could readily be implemented in most
laboratories for this purpose. Informed decisions on whether to offer
prophylactic therapy to unrelated contacts could then be reached after
both microbiological and capsular genotyping data were available.
Molecular typing methods.
Both short-term and long-term
epidemiological studies depend on reliable typing methods which can be
used to determine whether bacteria spread between individuals. The
results obtained by serological methods are not conclusive because many
isolates are not typeable and because the serotype and serosubtype are
not uniform even within highly related bacteria such as those of the
ET-37 complex (24) due to frequent horizontal genetic
exchange (21). Similarly, the ST55 bacteria described here
were variably serotype 4 and nontypeable (Table 2). Phylogenetic
methods based on multiple loci scattered around the chromosome are
necessary for reliable analysis of the relationships between bacteria
(3). Of these, the MLST method has been shown to be as
reliable as MLEE and even more conservative (18). The MLST
analysis showed unambiguously that the strains from the index patient
belonged to the ET-37 complex; almost all ET-37 complex strains are
ST11, and all ST11 strains belong to the ET-37 complex. MLST also
showed that none of the strains isolated from the 60 contacts were of
the ET-37 complex. Inefficient spread of ET-37 complex bacteria has
also been found in other investigations (1a, 20). Four
strains isolated from three carriers within one family all belonged to the novel ST ST55, and the three other carrier strains investigated belonged to three other STs. One of the latter was serogroup B, ET-5
complex, which has been associated with hyperendemic disease in many
countries (8).
PFGE is a typing method that is highly sensitive to microevolution and
was used to determine whether differences could be found between the
strains analyzed by MLST. The sensitivity of this method is
demonstrated by the observation that only a few bands were identical
between the representative ET-37 meningococci from Canada and the Czech
Republic or between those bacteria and the strains isolated from the
German patient. The results showed that the four carrier strains of
ST55 were almost identical, as were the two isolates from the patient.
The results also showed that a deletion of 40 kb of unknown
significance seemed to have occurred during invasion from the throat to
the bloodstream.
Relationships among ET-37 bacteria.
By the MLEE scheme ET-37
complex strains from patients with hyperendemic disease in Canada
differ from other ET-37 complex strains by one enzyme and have
therefore been referred to as "ET-15" (4). ET-37 strains
from recent outbreaks in the Czech Republic are indistinguishable by
MLEE from the Canadian strains (17), suggesting
that there might be an epidemiological link between disease in both
countries. The index patient described here became sick on the way
home from a trip to the Czech Republic and may therefore have been
colonized with ET-37 complex bacteria during that trip.
The data presented here do not support the differentiation of ET-15
strains and other strains of the ET-37 complex. All were identical by
MLST, but the Canadian and Czech strains differed markedly by
PFGE. The differences between these strains greatly exceed the
differences found by PFGE during clonal spread of serogroup A
meningococci (19), suggesting that these strains do not
share a recent common ancestor and that there may be no direct
epidemiological link between disease in Canada and disease in the
Czech Republic. Equally great differences were found between the
German isolate and the representative Czech strain, and the data
do not clarify where the patient was colonized. The genetic
variability of the ET-37 complex has not yet been analyzed by
PFGE, and numerous ET-37 complex strains isolated in the Czech Republic
and Germany might need to be investigated if the origin of the
German disease strain were to be clarified. However, such
analyses might fail if genomic rearrangements such as the 40-kb
deletion described here for the otherwise identical throat and blood
isolates of the patient were common among ET-37 meningococci.
 |
ACKNOWLEDGMENTS |
We gratefully acknowledge the expert technical assistance of
Gabriele Heinze, the receipt of strains from D. A. Caugant, and the receipt of MAbs from J. Suker.
 |
FOOTNOTES |
*
Corresponding author. Max-Planck-Institut für
molekulare Genetik, Ihnestr. 73, D-14195 Berlin, Germany. Phone: 49(30)
8413 1262. Fax: 49(30) 8413-1385. E-mail:
achtman{at}mpimg-berlin-dahlem.mpg.de.
 |
REFERENCES |
| 1.
|
Abdillahi, H., and J. T. Poolman.
1988.
Neisseria meningitidis group B serosubtyping using monoclonal antibodies in whole-cell ELISA.
Microb. Pathog.
4:27-32[Medline].
|
| 1a.
| Achtman, M. Unpublished data from Mali.
|
| 2.
|
Achtman, M.
1995.
Global epidemiology of meningococcal disease, p. 159-175.
In
K. Cartwright (ed.), Meningococcal disease. John Wiley & Sons, Ltd., Chichester, England.
|
| 3.
| Achtman, M. A phylogenetic perspective on
molecular epidemiology. In M. Sussman (ed.), Molecular
medical microbiology, in press. Academic Press, London, United Kingdom.
|
| 4.
|
Ashton, F. E.,
J. A. Ryan,
A. Borczyk,
D. A. Caugant,
L. Mancino, and D. Huang.
1991.
Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada.
J. Clin. Microbiol.
29:2489-2493[Abstract/Free Full Text].
|
| 5.
|
Begg, N.
1995.
Outbreak management, p. 285-305.
In
K. Cartwright (ed.), Meningococcal disease. John Wiley & Sons, Chichester, England.
|
| 6.
|
Borrow, R.,
H. Claus,
M. Guiver,
L. Smart,
D. M. Jones,
E. B. Kaczmarski,
M. Frosch, and A. J. Fox.
1997.
Non-culture diagnosis and serogroup determination of meningococcal B and C infection by a sialyltransferase (siaD) PCR ELISA.
Epidemiol. Infect.
118:111-117[Medline].
|
| 7.
|
Bygraves, J. A., and M. C. Maiden.
1992.
Analysis of the clonal relationships between strains of Neisseria meningitidis by pulsed field gel electrophoresis.
J. Gen. Microbiol.
138:523-531[Medline].
|
| 8.
|
Caugant, D. A.,
L. O. Froholm,
K. Bovre,
E. Holten,
C. E. Frasch,
L. F. Mocca,
W. D. Zollinger, and R. K. Selander.
1986.
Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease.
Proc. Natl. Acad. Sci. USA
83:4927-4931[Abstract/Free Full Text].
|
| 9.
|
Claus, H.,
U. Vogel,
M. Mühlenhoff,
R. Gerardy-Schahn, and M. Frosch.
1997.
Molecular divergence of the sia locus in different serogroups of Neisseria meningitidis expressing polysialic acid capsules.
Mol. Gen. Genet.
257:28-34[Medline].
|
| 10.
|
Edwards, U.,
A. Müller,
S. Hammerschmidt,
R. Gerardy-Schahn, and M. Frosch.
1994.
Molecular analysis of the biosynthesis pathway of the alpha-2,8 polysialic acid capsule by Neisseria meningitidis serogroup B.
Mol. Microbiol.
14:141-149[Medline].
|
| 11.
|
Frasch, C. E.,
W. D. Zollinger, and J. T. Poolman.
1985.
Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes.
Rev. Infect. Dis.
7:504-510[Medline].
|
| 11a.
| Frosch, M. Unpublished data.
|
| 12.
|
Frosch, M.,
U. Edwards,
K. Bousset,
B. Krauße, and C. Weisgerber.
1991.
Evidence for a common molecular origin of the capsule gene loci in gram-negative bacteria expressing group II capsular polysaccharides.
Mol. Microbiol.
5:1251-1263[Medline].
|
| 13.
|
Halter, R.,
J. Pohlner, and T. F. Meyer.
1989.
Mosaic-like organization of IgA protease genes in Neisseria gonorrhoeae generated by horizontal genetic exchange in vivo.
EMBO J.
8:2737-2744[Medline].
|
| 14.
|
Hammerschmidt, S.,
R. Hilse,
J. P. van Putten,
R. Gerardy-Schahn,
A. Unkmeir, and M. Frosch.
1996.
Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element.
EMBO J.
15:192-198[Medline].
|
| 15.
|
Hammerschmidt, S.,
A. Müller,
H. Sillmann,
M. Mühlenhoff,
R. Borrow,
A. Fox,
J. van Putten,
W. D. Zollinger,
R. Gerardy-Schahn, and M. Frosch.
1996.
Capsule phase variation in Neisseria meningitidis serogroup B by slipped strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease.
Mol. Microbiol.
20:1211-1220[Medline].
|
| 16.
|
Knight, A. I.,
K. A. Cartwright, and J. McFadden.
1990.
Identification of a UK outbreak strain of Neisseria meningitidis with a DNA probe.
Lancet
335:1182-1184[Medline].
|
| 17.
|
Krizova, P., and M. Musilek.
1995.
Changing epidemiology of meningococcal invasive disease in the Czech Republic caused by new clone Neisseria meningitidis C:2a: P1.2(P1.5), ET-15/37.
Cent. Eur. J. Public Health
3:189-194[Medline].
|
| 18.
|
Maiden, M. C.,
J. A. Bygraves,
E. Feil,
G. Morelli,
J. E. Russell,
R. Urwin,
Q. Zhang,
J. Zhou,
K. Zurth,
D. A. Caugant,
I. M. Feavers,
M. Achtman, and B. G. Spratt.
1998.
Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms.
Proc. Natl. Acad. Sci. USA
95:3140-3145[Abstract/Free Full Text].
|
| 19.
|
Morelli, G.,
B. Malorny,
K. Muller,
A. Seiler,
J. Wang,
J. del Valle, and M. Achtman.
1997.
Clonal descent and microevolution of Neisseria meningitidis during 30 years of epidemic spread.
Mol. Microbiol.
25:1047-1064[Medline].
|
| 20.
|
Ronne, T.,
L. Berthelsen,
L. H. Buhl, and I. Lind.
1993.
Comparative studies on pharyngeal carriage of Neisseria meningitidis during a localized outbreak of serogroup C meningococcal disease.
Scand. J. Infect. Dis.
25:331-339[Medline].
|
| 21.
|
Suker, J.,
I. M. Feavers,
M. Achtman,
G. Morelli,
J. F. Wang, and M. C. Maiden.
1994.
The porA gene in serogroup A meningococci: evolutionary stability and mechanism of genetic variation.
Mol. Microbiol.
12:253-265[Medline].
|
| 22.
|
Swaminathan, B.,
G. M. Matar,
M. W. Reeves,
L. M. Graves,
G. Ajello,
W. F. Bibb,
L. O. Helsel,
M. Morales,
H. Dronavalli,
M. el Swify,
W. DeWitt, and S. B. Hunter.
1996.
Molecular subtyping of Neisseria meningitidis serogroup B: comparison of five methods.
J. Clin. Microbiol.
34:1468-1473[Abstract].
|
| 23.
|
Swartley, J. S.,
A. A. Marfin,
S. Edupuganti,
L. J. Liu,
P. Cieslak,
B. Perkins,
J. D. Wenger, and D. S. Stephens.
1997.
Capsule switching of Neisseria meningitidis.
Proc. Natl. Acad. Sci. USA
94:271-276[Abstract/Free Full Text].
|
| 24.
|
Wang, J. F.,
D. A. Caugant,
G. Morelli,
B. Koumare, and M. Achtman.
1993.
Antigenic and epidemiologic properties of the ET-37 complex of Neisseria meningitidis.
J. Infect. Dis.
167:1320-1329[Medline].
|
| 25.
|
Woods, J. P.,
D. Kersulyte,
R. W. Tolan, Jr.,
C. M. Berg, and D. E. Berg.
1994.
Use of arbitrarily primed polymerase chain reaction analysis to type disease and carrier strains of Neisseria meningitidis isolated during a university outbreak.
J. Infect. Dis.
169:1384-1389[Medline].
|
Journal of Clinical Microbiology, September 1998, p. 2465-2470, Vol. 36, No. 9
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Bergfeld, A. K., Claus, H., Vogel, U., Muhlenhoff, M.
(2007). Biochemical Characterization of Thepolysialic Acid-specific O-Acetyltransferase NeuO of Escherichia coli K1. J. Biol. Chem.
282: 22217-22227
[Abstract]
[Full Text]
-
Knaust, A., Weber, M. V. R., Hammerschmidt, S., Bergmann, S., Frosch, M., Kurzai, O.
(2007). Cytosolic Proteins Contribute to Surface Plasminogen Recruitment of Neisseria meningitidis. J. Bacteriol.
189: 3246-3255
[Abstract]
[Full Text]
-
Madico, G., Welsch, J. A., Lewis, L. A., McNaughton, A., Perlman, D. H., Costello, C. E., Ngampasutadol, J., Vogel, U., Granoff, D. M., Ram, S.
(2006). The Meningococcal Vaccine Candidate GNA1870 Binds the Complement Regulatory Protein Factor H and Enhances Serum Resistance. J. Immunol.
177: 501-510
[Abstract]
[Full Text]
-
Harmsen, D., Claus, H., Witte, W., Rothganger, J., Claus, H., Turnwald, D., Vogel, U.
(2003). Typing of Methicillin-Resistant Staphylococcus aureus in a University Hospital Setting by Using Novel Software for spa Repeat Determination and Database Management. J. Clin. Microbiol.
41: 5442-5448
[Abstract]
[Full Text]
-
Clarke, S. C., Diggle, M. A., Edwards, G. F. S.
(2001). Semiautomation of Multilocus Sequence Typing for the Characterization of Clinical Isolates of Neisseria meningitidis. J. Clin. Microbiol.
39: 3066-3071
[Abstract]
[Full Text]
-
Claus, H., Stoevesandt, J., Frosch, M., Vogel, U.
(2001). Genetic Isolation of Meningococci of the Electrophoretic Type 37 Complex. J. Bacteriol.
183: 2570-2575
[Abstract]
[Full Text]
-
Ala'Aldeen, D. A. A., Neal, K. R., Ait-Tahar, K., Nguyen-Van-Tam, J. S., English, A., Falla, T. J., Hawkey, P. M., Slack, R. C. B.
(2000). Dynamics of Meningococcal Long-Term Carriage among University Students and Their Implications for Mass Vaccination. J. Clin. Microbiol.
38: 2311-2316
[Abstract]
[Full Text]
-
Jelfs, J., Munro, R., Wedege, E., Caugant, D. A.
(2000). Sequence Variation in the porA Gene of a Clone of Neisseria meningitidis during Epidemic Spread. CVI
7: 390-395
[Abstract]
[Full Text]
-
Riesbeck, K., Orvelid-Mölling, P., Fredlund, H., Olcén, P.
(2000). Long-Term Persistence of a Discotheque-Associated Invasive Neisseria meningitidis Group C Strain as Proven by Pulsed-Field Gel Electrophoresis and porA Gene Sequencing. J. Clin. Microbiol.
38: 1638-1640
[Abstract]
[Full Text]
-
Claus, H., Friedrich, A., Frosch, M., Vogel, U.
(2000). Differential Distribution of Novel Restriction-Modification Systems in Clonal Lineages of Neisseria meningitidis. J. Bacteriol.
182: 1296-1303
[Abstract]
[Full Text]
-
Vogel, U., Claus, H., Frosch, M.
(2000). Rapid Serogroup Switching in Neisseria meningitidis. NEJM
342: 219-220
[Full Text]
-
Feavers, I. M., Gray, S. J., Urwin, R., Russell, J. E., Bygraves, J. A., Kaczmarski, E. B., Maiden, M. C. J.
(1999). Multilocus Sequence Typing and Antigen Gene Sequencing in the Investigation of a Meningococcal Disease Outbreak. J. Clin. Microbiol.
37: 3883-3887
[Abstract]
[Full Text]
-
Vogel, U., Claus, H., Heinze, G., Frosch, M.
(1999). Role of Lipopolysaccharide Sialylation in Serum Resistance of Serogroup B and C Meningococcal Disease Isolates. Infect. Immun.
67: 954-957
[Abstract]
[Full Text]